Targeted gene therapy offers relief from pain and inflammation
Aditi Bhargava, PhD
Chronic pain affects an estimated 116 million Americans and costs $635 billion each year in medical treatment and lost productivity.
Aditi Bhargava, PhD, associate professor at UCSFs School of Medicine, is using a technique known as RNA interference (RNAi) to develop a gene therapy system that sends specific commands to certain neurons, or nerve cells, telling them to turn off pain, or stop inflammation.
The current treatments for pain dull everything, Bhargava says. You have a little fire in the kitchen, but your only solution is a fire hose that floods the entire house. You put out the fire, but youre affecting the whole house in the process a huge negative side effect.
Likening her method to a Trojan horse, Bhargavas novel therapeutic approach essentially hides the pain-silencing commands, carried by distinct proteins that affect cellular function, inside other proteins which bind only to the troublemaker cells. Once attached, they release their hidden power.
We want to target the small or medium neurons that sense pain, while leaving other neurons unaffected, she says. Were hoping that while you reduce pain, for example, youll still be able to chew or not drool.
The data from her proof-of-concept animal studies look promising, Bhargava said. I believe that this project has tremendous translational potential to turn what we learn into concrete benefits for patients.
Targeted pain and inflammation relief could also be used to treat illnesses, such as Inflammatory Bowel Disease (IBD), an autoimmune condition. This approach has potential to not only minimize unwanted side-effects, but save costs, as it sends very small amounts of drug therapies to the targeted cells.
Targeted delivery of drug would reduce the dose required to treat, reduce cost, and most importantly, reduce unwanted side-effects.
However, Bhargavas work is in the early stages, and shes now facing the critical next steps of moving from animal models to studies with humans, a phase she describes as complex and challenging.
Customized Support to Develop Early-Stage Ideas
To get help tailored to her individual needs, Bhargava applied for a T1 Translational Catalyst Award, granted by UCSFs Clinical and Translational Science Institute (CTSI). The award is designed to help drive promising, early-stage research through the lengthy and complex process of translating promising ideas into patient benefit.
The CTSI T1 Catalyst Award works with a tiered model that provides increasing benefit at each of three phases, beginning with feedback and analysis of all proposals. In the second phase, a selected number of awardees are chosen to receive expert consultation from a customized panel of technical, clinical, and business experts.
During this consultation period, applicants are also eligible to apply for a pilot award of up to $15,000 to be used toward a critical experiment or study that may strengthen the proposal. In the final phase, funds of up to $100,000 are awarded to one or more applicants to develop proposals further.
Many recipients point to individualized consultation with industry, legal, and regulatory experts as the most valuable element of the T1 Catalyst award process, said Ruben Rathnasingham, PhD, a senior program manager with CTSIs Early Translational Research program, which administers the award. Applicants have found that expert advice that steers their research toward greater commercial and clinical utility often opens new doors to funding opportunities that were previously unavailable.
For researchers who have a well-developed idea with promising data, yet struggle to breach the gap between early research and clinical practice, the T1 Catalyst Award offers an indispensable opportunity, he added.
In the case of Dr. Bhargava, her work was very innovative and we immediately saw its potential clinical relevance, Rathnasingham said. Connecting her with an industry veteran has helped her tap into the full capabilities of her innovation, as well as provide a clear path forward.
Bhargava was matched with Alex Bajamonde, then a biostatistician at Genentech, who suggested she focus on developing the method for wider applications, including delivering therapies.
The advice was illuminating, Bhargava says. Working with someone who has done this is much better than reinventing the wheel. We obviously needed help scaling it up.
Based on consultant feedback, and supported by a $15,000 Pilot Award from the T1 Catalyst Program, she revised her proposal to test her method with other localized diseases, such as Inflammatory Bowel Disease, one of her areas of expertise. She used it to send a proven Bowel Disease antibody that blocks inflammation directly to the affected part of the intestine. We found a dramatic reduction in inflammation, and we think the side effects will be much less, she says.
While her investigation is on stronger footing than before the consultation, Bhargava cautions that far more research is needed. With the support of new data, shes now working to get a patent on her innovation.
In another indication that shes on a promising path, Bhargava, and her collaborator, Dr. Peter Ohara, UCSF Professor of Anatomy, recently secured an additional $100,000 in funding from a private donor and thePainless Research Foundation.
CTSI is a member of the National Institutes of Health-funded Clinical and Translational Science Awards network. Under the banner of Accelerating Research to Improve Health, it provides a wide range of services for researchers, and promotes online collaboration and networking tools such as UCSF Profiles.
Provided by University of California, San Francisco
- New pill recognition software has implications for emergency and clinical settings Apr 16, 2012 | not rated yet | 0
- UCSF experts highlight need for innovation in recruiting participants for clinical trials Dec 23, 2011 | not rated yet | 0
- Study finds e-medical records have varying effects on productivity Dec 16, 2010 | not rated yet | 0
- Autoimmune diseases the target of new research Mar 13, 2012 | not rated yet | 0
- Scientists discover new inflammatory target May 09, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Dipole term in multipole expansion
2 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
3 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
13 hours ago Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
Current leading voltage or vice versa concept
15 hours ago Hello, I was wondering if there is a conceptual explanation for when current leads voltage or vice versa for capacitors or inductors with AC...
Angular Frequency of AC voltage
18 hours ago Hello, I am wondering, what is the physical interpretation of the angular frequency of AC voltage? I don't see the physicality of what the angle...
Modeling Rigid Body - Unsure about Euler angles and angular velocity
18 hours ago I'm modeling a single 3D rigid body in preparation for some more complicated modeling in order to gain a better understanding of Euler angles, the...
- More from Physics Forums - Classical Physics
More news stories
The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study.
Inflammatory disorders 6 hours ago | not rated yet | 0
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...
Inflammatory disorders May 20, 2013 | 4 / 5 (1) | 0
(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause ...
Inflammatory disorders May 14, 2013 | not rated yet | 0 |
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders May 08, 2013 | not rated yet | 0
Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks ...
Inflammatory disorders May 07, 2013 | 4.5 / 5 (2) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
8 minutes ago | not rated yet | 0 |
(HealthDay)—The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or ...
18 minutes ago | not rated yet | 0
(HealthDay)—In 2008 to 2010, the prevalence of key health behaviors among U.S. adults varied, with about one in five adults current smokers and 62.1 percent overweight or obese, according to a report presented ...
8 minutes ago | not rated yet | 0
Early use of tracheostomy for mechanically ventilated patients not associated with improved survival
For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...
8 minutes ago | not rated yet | 0
(HealthDay)—The monstrous tornado that devastated Moore, Okla., on Monday, killing dozens of adults and children, is a stunning example of violent weather that can affect a child's mental well-being.
28 minutes ago | not rated yet | 0
The globe remains unprepared to deal with the risk of a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads ...
28 minutes ago | not rated yet | 0